Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT05560724

Network Properties As Biomarkers for Non-Invasive Brain Stimulation (NIBS) After Stroke

Led by Universitätsklinikum Hamburg-Eppendorf · Updated on 2024-12-17

81

Participants Needed

1

Research Sites

208 weeks

Total Duration

On this page

Sponsors

U

Universitätsklinikum Hamburg-Eppendorf

Lead Sponsor

G

German Research Foundation

Collaborating Sponsor

AI-Summary

What this Trial Is About

The present study will evaluate the potential of cortico-cerebellar network properties derived from neuroimaging in a group of chronic stroke patients to explain inter-subject variability in responsiveness to transcranial direct current stimulation (tDCS) targeting the cortico-spinal and cortico-cerebellar network.

CONDITIONS

Official Title

Network Properties As Biomarkers for Non-Invasive Brain Stimulation (NIBS) After Stroke

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients after first-ever clinical ischemic stroke in the early (>3 months) or later chronic (>6 months) stage of recovery
  • Persistent motor deficit of the upper extremity
  • Stroke location: supratentorial
  • Age over 18 years
  • Written informed consent obtained
Not Eligible

You will not qualify if you...

  • Contraindication against MRI and tDCS
  • Known epilepsy or previous epileptic seizure
  • Presence of electrical implants such as brain stimulators
  • Medical history suggesting more than one previous stroke
  • Severe polyneuropathy or peripheral ischemic vascular diseases critically affecting upper limb sensorimotor function
  • Active drug or alcohol abuse
  • Active and severe psychiatric diseases (e.g., psychosis)
  • Severe cognitive deficits (Mini Mental State Examination score ≤ 23)
  • Uncontrolled medical problems such as cardiovascular diseases, unstable arrhythmia, or arthritis

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

University Medical Center Hamburg-Eppendorf, Dept. of Neurology

Hamburg, Free and Hanseatic City of Hamburg, Germany, 20246

Actively Recruiting

Loading map...

Research Team

R

Robert Schulz, PD Dr. med.

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

BASIC_SCIENCE

Number of Arms

3

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here